About MedArrive
MedArrive is a private company based in New York, New York, incorporated in 2018 in Delaware. It has reported $40,843,775 raised in two offerings on Form D since February 2022. Its chief executive is Daniel Trigub.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Mar 31, 2023 | Apr 11, 2023 | $8,000,000of $10.0M target | 1 | $8.0M | OptionsRule 506(c) | Form D ↗ |
| Jan 28, 2022 | Feb 11, 2022 | $32,843,775of $32.8M target | 41 | $801K | EquityRule 506(b) | Form D ↗ |
| Total, two offerings | $40,843,775 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on MedArrive's Form D filed Apr 11, 2023.
AB
Agneta Breitenstein
Director
IP
Inna Plumb
Executive officer
WS
William Sullivan
Director
AC
Annie Case
Director
DT
Daniel Trigub
CEO and director
AH
Andy Harrison
Director
Earlier filings also listed Lynne O'Keefe (director, last listed Feb 2022).